{"schema_version":"secwatch.filing_event.v1","accession":"0001206774-21-001938","form_type":"8-K","ticker":"CLX","cik":"0000021076","company_name":"CLOROX CO /DE/","filed_at":"2021-08-03T23:59:59+00:00","discovered_at":"2026-05-14T18:04:20.218398+00:00","generated_at":"2026-06-29T23:32:07.186248+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"medium","headline":"Clorox Q4 EPS sinks 68%, sales fall 9%; FY margins contract sharply","bullets":["Q4 diluted EPS $0.81, down 68% YoY; full-year diluted EPS down 24%.","Q4 net sales declined 9% with organic sales down 10%; Health & Wellness segment sales down 17%.","Gross margin in Q4 fell to 37.1% from 46.8% a year ago, driven by higher commodity and supply-chain costs.","Full-year free cash flow $945M vs $1,292M prior year; capital expenditures $331M.","Company delivered over $120M in cost savings; e-commerce nearly doubled in two years."],"urls":{"canonical":"https://secwatch.observer/filing/0001206774-21-001938","json":"https://secwatch.observer/filing/0001206774-21-001938.json","markdown":"https://secwatch.observer/filing/0001206774-21-001938.md","text":"https://secwatch.observer/filing/0001206774-21-001938.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/21076/000120677421001938/0001206774-21-001938-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/21076/000120677421001938/clorox3938801-8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T23:32:07.186248+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}